1991; Xu et al., 1995; Draper et al., 1998) . Follistatin also Serum concentrations of inhibin A, inhibin B, activin A decreases FSH secretion by binding activin, thereby preventing and follistatin were determined using two-site enzymethe interaction of activin with its receptor (Cataldo et al., linked immunosorbent assays (ELISA) during pubertal 1994; de Winter et al., 1996) . ovarian development in 28 girls and five follicular phase
The recent advent of specific, two-site immunoassays for women. Blood obtained every 15 to 20 min overnight inhibin A and B and activin A has made it possible to measure was pooled for peptide determination. Serum inhibin A these regulatory peptides in the peripheral circulation. Initial concentrations increased in mid puberty, exhibiting positive studies utilizing these assays have suggested an endocrine role correlations with bone age (r ⍧ 0.527, P ⍧ 0.0016) and for inhibin A and B in the control of FSH secretion during oestradiol concentrations (r ⍧ 0.581, P ⍧ 0.0005). Inhibin the menstrual cycle in combination with oestradiol (Groome B concentrations peaked in mid puberty and declined et al., 1994 Welt et al., 1997; Hayes et al., 1998) .
thereafter, but remained greater than concentrations seen
Perimenopausal women have an age-related increase in in prepubertal girls, and correlating positively with serum FSH concentration that precedes a decline in serum oestradiol (r ⍧ 0.362, P ⍧ 0.046) and follicle stimulating oestradiol concentration (Yen, 1991) . In these women, activin hormone (FSH) concentrations (r ⍧ 0.369, P ⍧ 0.038).
A concentrations increase while inhibin B concentrations Total activin A concentrations did not vary significantly decrease, suggesting that the sum change in concentrations of across pubertal stages. Total follistatin concentrations, positive regulators of FSH (activin and GnRH), and negative determined by radioimmunoassay, decreased with advancregulators of FSH (oestradiol, inhibin and follistatin) may ing puberty, exhibiting negative correlations with bone together contribute to the increases in FSH secretion seen in age (r ⍧ -0.634, P ⍧ 0.0001) and oestradiol concentration ageing (Reame et al., 1998) . (r ⍧ -0.687, P ⍧ 0.0001). Follistatin concentrations Whether gonadal peptides regulate FSH secretion during determined by an ELISA specific for follistatin 288 were pubertal maturation is unclear. Recent studies have shown that greatest in mid-pubertal girls, but concentrations in late inhibin B concentrations are greater in prepubertal boys than puberty were less than those in early puberty. The free in prepubertal girls, suggesting that the greater FSH concentrafollistatin assay indicated that all circulating follistatin tions seen in prepubertal girls could be related to less inhibin was activin-bound. These results suggest that significant availability from the developing ovary (Hayes et al., 1998) . changes in serum concentrations of FSH-regulatory pepPrepubertal girls, unlike prepubertal boys, readily release FSH tides accompany the onset of puberty.
into the circulation in response to GnRH administration (Lee, Key words: activin A/follistatin/girls/inhibin A and B/puberty 1985; . Ovarian size increases throughout the prepubertal period and into puberty as a consequence of increased stroma, growth of individual follicles and growth of number of follicles (Peters et al., 1978) . Thus, the developing Introduction gonad could produce increasing concentrations of gonadal Gonadotrophins are secreted episodically under the influence peptides that in turn could affect FSH secretion. Since activin of gonadotrophin-releasing hormone (GnRH), but sex steroid and follistatin are produced in the pituitary (Ying, 1988; DePaolo et al., 1991) , there is also the possibility that changes in the peripheral concentrations of activin and follistatin may interviewed about their menstrual history before inclusion in the enzyme-linked immunosorbent assays (ELISA) (Serotec, Raleigh, NC, USA). The sensitivities of the assays were 0.2 ng/ml, 5 pg/ml a According to the method of Tanner (Tanner, 1978) . b CEP ϭ constitutional early puberty; CGD ϭ constitutional growth delay;
and 16 pg/ml for activin A, inhibin A and inhibin B respectively.
FSS ϭ familial short stature; FTS ϭ familial tall stature; IGHD ϭ isolated
The samples were measured in one assay in triplicate. The intragrowth hormone deficiency; IUGR ϭ intrauterine growth retardation; assay coefficients of variation were 5, 8 and 6% for activin A, inhibin LTF ϭ lost to follow-up; NL ϭ normal subject; SS ϭ short stature;
A and inhibin B respectively.
Y ϭ yes (spontaneous menses).
Total follistatin concentrations were determined using a heterologous radioimmunoassay described previously (O'Connor et al., that regulates FSH secretion (Bilezikjian et al., 1994) . This 1999) which employs dissociating reagents [20% Tween 20, 10% study was designed to determine whether the gonadal peptides, sodium deoxycholate and 0.4% sodium dodecyl sulphate (SDS)], to activin A, inhibin A, inhibin B and follistatin, are correlated remove the interference of bound activin. The rabbit polyclonal with maturation markers in girls. Such a correlation would antiserum used in this assay was raised against 35 kDa bovine suggest that gonadal peptides could contribute to the changes follistatin. In the assay, recombinant human follistatin (rhFS) 288 in FSH concentration that occur at puberty. was used as both tracer and standard. Cross-reactivity was 100% for rhFS 288 and 36% for rhFS 315 (O'Connor et al., 1999) . In the
Materials and methods
presence of dissociating reagents, addition of increasing amounts of activin did not alter the amount of measured follistatin (O'Connor Subjects et al., 1999) . The assay sensitivity was 1.6 ng/ml, and the intra-assay Twenty-eight healthy girls were referred for study because of short coefficient of variation 12.3%. Samples of human male and female or tall stature, adolescent delay, or early puberty. All cases of early serum diluted parallel in the assay, and the recovery of added puberty were constitutional. Subject characteristics are shown in follistatin (3.125-100 ng/ml) ranged from 103 to 110% (O'Connor Table I . Previously published methods were used to determine stages et al., 1999) . Follistatin 288 concentrations were measured using a of puberty (Tanner, 1978) and bone age (Greulich and Pyle, 1955) .
recently developed two-site ELISA (Evans et al., 1998) . The assay Body mass indices did not vary among groups and were approsensitivity was 37 pg/ml and the intra-assay coefficient of variation priate for bone age (data not shown). All of the prepubertal girls 17%. This assay cross-reacts 9.9% with follistatin 315 (Evans et al., studied subsequently had spontaneous onset of pubertal development. 1998). Free follistatin was determined by a second-generation twoSeventeen of the 28 have established regular menstrual cycles; the site chemiluminescent assay that utilizes two monoclonal antibodies remainder have been lost to follow-up. Four girls (two in stage I and generated against non-overlapping epitopes of human follistatin as two in stage II puberty) had a peak growth hormone (GH) concentradescribed previously (McConnell et al., 1998) . The assay sensitivity tion Ͻ8 ng/ml after two provocative stimuli and were treated with was 0.8 ng/ml, and the intra-assay coefficient of variation Ͻ4%. exogenous GH after this study. Each of these girls had spontaneous LH and FSH were determined by immunofluorometric assay using onset of puberty, and three have regular menstrual cycles. In addition, commercially available kits (Wallac, Gaithersburg, MD, USA). The five adult women who were in the follicular phase of the menstrual assay sensitivity was 0.05 IU/l for LH and FSH. The intra-assay cycle were also studied and are grouped as stage V puberty. Subjects were studied within 5 days of the onset of menses. Each was coefficients of variation were 3.1% for LH and 3.9% for FSH. 
Statistical analyses

Gonadotrophin concentrations
As expected, mean serum LH and FSH concentrations each a P Ͻ 0.0001; b P Ͻ 0.001; c P Ͻ 0.01; d P Ͻ 0.05.
increased with advancing pubertal stage (Figure 1 ). The increase in LH was progressive across puberty through stage Inhibin A, inhibin B and activin A concentrations III. There was a robust correlation between bone age and LH concentration (r ϭ 0.656, P ϭ 0.0001; Table II) . FSH Inhibin A concentrations increased between stage II and III puberty and remained at similar concentrations in stage IV concentrations increased between stages I and II but were relatively constant thereafter and were also positively correlated and V puberty (Figure 1 ). Inhibin A concentrations exhibited a positive correlation with bone age (r ϭ 0.527; P ϭ 0.0016; with bone age (r ϭ 0.444, P ϭ 0.0096; Table II) . Table II) . Inhibin B concentrations increased between stage I observed in boys or in a previously reported longitudinal study in girls (Crofton et al., 1997) . It is difficult to make any and II puberty, reached a peak in stage III puberty, and decreased thereafter. The correlation with bone age was not meaningful comparisons between the current and the published report (Crofton et al., 1997) , as there were four girls in stage significant (r ϭ 0.172). Activin A concentrations did not differ significantly with pubertal stage, although the trend in III puberty available for inclusion in the current study, while only one girl had a sample obtained at stage III puberty in the concentrations at each pubertal stage mirrored those of inhibin B (Figure 1) . study of Crofton et al. Further, earlier studies (Andersson et al., 1997; Crofton et al., 1997) utilized single samples in Follistatin concentrations their design, while the current study design incorporated an integrated measure over a 10 h period at night when Total follistatin concentrations had an apparent decrease gonadotrophin secretion is most active in pubertal children between pubertal stages I to IV and stage V puberty (Figure (Penny et al., 1977; Foster et al., 1989; Cemeroglu et al., 1) , exhibiting a significant decrease with advancing bone 1996; Kletter et al., 1997) . It is also of interest that in an age (r ϭ -0.634; P ϭ 0.0001; Table II ). Free follistatin earlier study (Boepple et al., 1996) , inhibin B concentrations concentrations were near the limit of assay detection in all found in girls with precocious puberty were similar to those subjects (Figure 1) . When determined by an ELISA specific in adult women, and inhibin B concentration declined when for follistatin 288, follistatin concentrations exhibited a peak gonadotrophin secretion was down-regulated with GnRH agonin stage III puberty and declined significantly thereafter.
ist therapy. Since inhibin B is found in granulosa cells of Analysis of the relationship between follistatin 288 concentradeveloping follicles (Roberts et al., 1993) , the general increase tion and bone age showed that r ϭ -0.321 (not significant).
in numbers of developing follicles during mid puberty may Correlation of gonadal peptides with FSH and oestradiol contribute to the increased concentrations of inhibin B observed in the mid-pubertal girls of the current investigation. Studies FSH concentrations demonstrated a positive correlation with relating inhibin B concentrations to changes in follicular size increasing concentrations of oestradiol and LH (Figure 1 , and oestradiol and progesterone concentrations in the pubertal Table II ). There was a positive correlation between inhibin transition may shed additional light on how gonadal peptide B concentration and FSH concentration, but no significant concentrations change with ovarian development. correlations between inhibin A, activin A, or follistatin and As both inhibin A and B suppress FSH secretion (Ying, FSH concentrations (Table II) . There were positive correla-1987), the sum total of inhibin A and inhibin B should provide tions between oestradiol concentration and inhibin A and B an index of total peripheral inhibin input. Estimation of total concentrations, but not with activin A concentration (Table  inhibin by summing inhibin A and inhibin B concentrations II). Total follistatin concentration had a significant negative suggests that total inhibin concentrations increase through mid correlation with oestradiol concentration, but there was no puberty and decline thereafter. The directionality of inhibin correlation between oestradiol concentration and follistatin changes is dictated by the higher circulating concentrations of 288 concentration (Table II) .
inhibin B. Until it is established that these two immunoassays predict the protein mass of inhibin A and B correctly, and it Discussion is demonstrated that the relative biological potency of these two isomers in suppressing human FSH secretion is similar, In this study, changes in activin A, inhibin A and B, and follistatin concentrations during pubertal development in girls this estimate should be viewed with caution. Correlation data between hormone concentrations do not were examined, and changes in gonadal peptide concentrations were correlated to the developmental marker of bone age and imply a cause-and-effect relationship, but are of interest in determining whether a relationship may be present. Hence, the with FSH and oestradiol concentrations. The results indicate that the concentrations of two negative regulators of FSH correlation coefficients between the gonadal peptides and FSH and oestradiol concentrations were determined in the subject secretion inhibin A and total follistatin change in opposite directions during progression of puberty. Inhibin concentrapopulation of this study. Previously, it was reported that both inhibin A and B concentrations exhibit positive correlations tions increased while follistatin concentrations decreased with pubertal progression in girls. Total concentrations of the with oestradiol and FSH concentrations (Crofton et al., 1997 ).
In the current study, only inhibin B and not inhibin A positive regulator of FSH, activin A, remain unchanged during pubertal progression. The decline in follistatin, a binding concentrations exhibited a significant correlation with FSH. The positive correlation between inhibin B and FSH suggests neutralizer of activin, in the face of relatively constant total activin A concentrations suggests that the bioavailable activin that the increase in FSH may actually drive the increase in inhibin B and-at least during puberty-inhibin B may not be (free activin A) increases with pubertal progression, such that activin could contribute to the increase in FSH that occurs negatively regulating FSH secretion. Such a relationship is also seen with oestradiol and gonadotrophin secretion. during puberty.
Changes in inhibins in this study agree in general with those FSH is believed to increase oestradiol secretion during puberty, and the profound negative feedback of oestradiol on observed in earlier studies. In both boys and girls, inhibin concentrations are lowest during pubertal stage I (Andersson gonadotrophin secretion seen in prepubertal children is lost during puberty. This appears to be due to a change in et al., 1997). However, the mid-pubertal peak in inhibin B that was noted in the girls in the current study has not been neurotransmitter control of GnRH secretion which results in resistance of the hypothalamus to negative feedback. As follistatin concentration has a significant inverse correlation with oestradiol concentration suggests that increasing oestradiol puberty progresses, the pituitary gonadotroph assumes increasing importance over the hypothalamus as the site of concentrations with advancing puberty might be responsible sex steroid negative feedback (Kletter et al., 1992 ; Cemeroglu for suppressing follistatin, but additional studies will be needed et al., 1998) . This change of feedback appears to permit the to demonstrate a cause-and-effect relationship. increase of gonadotrophin secretion seen at puberty. If gonadal
The data in this study, coupled with other recent findings, peptides exhibit their primary endocrine effects at the level of indicate that inhibin concentrations vary dynamically with the pituitary, negative feedback may not be possible until pubertal maturation. Changes in inhibins during pubertal gonadotrophin secretion from the pituitary is well established, maturation seem to be a reflection of ovarian maturation rather as in late puberty. As inhibin A and B concentrations both than an indicator of FSH feedback regulation. Activin A increase significantly with the increase in oestradiol concentraconcentrations do not vary significantly with pubertal maturations, and inhibin B concentrations increase significantly with tion, but the decline in follistatin concentrations with increasing FSH concentrations, these data suggest that inhibin conpubertal maturation suggests that more activin could be availcentration may serve as a developmental marker of ovarian able to increase pituitary FSH release as the ovary develops. follicle development or increase in follicle number during Analysis of dynamic changes of all gonadal peptides will be puberty.
needed to understand whether and how these peptides function The cross-sectional data in this study suggest that activin in the complex regulation of gonadotrophin secretion. concentrations do not change significantly with advancing puberty. Activin assays are relatively new (Knight et al., 1996) , and hence this is the first report on changes in activin
